Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals is a biopharmaceutical company focused on RNA interference therapeutics, with its primary political signal being a single executive branch holding by Donald J. Trump valued between $1,001 and $15,000.
BusinessWhat ALNY does
Alnylam Pharmaceuticals develops and commercializes RNAi therapeutics for genetically defined diseases. Its revenue is derived from product sales of its approved medicines and collaboration revenues from partnerships. The company operates in the biotechnology and pharmaceutical sectors.
6 months past · 3 months futureALNY activity timeline
Executive Branch ConflictsALNY held by Trump-administration officials
Lifetime Government AwardsALNY federal contracts
ALNY doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Smart Money · 13F HoldingsHedge funds holding ALNY
Politicians Trading ALNYMembers of Congress with recent ALNY positions
Congressional TradesWho in Congress is trading ALNY
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills Affecting ALNYLive legislation impacting this stock
Political ProfileWhere ALNY sits in Washington
[object Object]
STRUCTURAL: No lobbying spend (`get_political_influence.lobbying.total_income`: $0), no donations, and no federal contracts. EVIDENTIARY: One executive branch holding (`get_executive_branch_exposure.by_ticker[0].holdings[0].value_bucket`: $1,001-$15,000) and two congressional sales (`Top congressional traders`: 2 sales by S001229). Net: Minimal direct political engagement against high regulatory density.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Broad legislative exposure to healthcare pricing or reimbursement reforms.U.S. Congress"8 recent bills with sector='healthcare' and impact_ratio > 0 per `Recent bill_impacts`."
Regulatory opportunities
- No specific regulatory opportunities flagged.
Live signals + predictions for ALNY — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades ALNY
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord